National Organization for Rare Disorders, Inc.
It is possible that the main title of the report Relapsing Polychondritis is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report.
- chronic atrophic polychondritis
- generalized or systemic chondromalocia
- Meyenburg-Altherr-Uehlinger syndrome
- relapsing perichondritis
- von Meyenburg disease
Related Disorders List
Information on the following diseases can be found in the Related Disorders section of this report:
Relapsing polychondritis is a rare degenerative disease characterized by recurrent inflammation of the cartilage in the body. Deterioration of the cartilage may affect any site of the body where cartilage is present. Ears, larynx and trachea may become "floppy," and the bridge of the nose can collapse into a "saddlenose" shape. The aortic heart valve may also be affected.
Symptoms of relapsing polychondritis usually begins with the sudden onset of pain, tenderness and swelling of the cartilage of one or both ears. This inflammation may spread to the fleshy portion of the outer ear causing it to narrow. Attacks may last several days to weeks before subsiding. Middle ear inflammation can cause obstruction of the eustachian tube. Recurrent attacks may lead to hearing loss.
Nasal Chondritis may be marked by cartilage collapse at the bridge of the nose resulting in a saddlenose deformity, nasal stuffiness or fullness and crusting.
Inflammation of both large and small joints can occur. Classic symptoms of pain and swelling are similar to those of arthritis.
Involvement of the cartilage of the larynx and bronchial tubes may cause breathing and speech difficulties.
Heart valve abnormalities may occur.
Relapsing polychondritis may also cause kidney inflammation and dysfunction.
The exact cause of relapsing polychondritis is not known. It is thought to be an autoimmune disease. Autoimmune disorders are caused when the body's natural defenses against "foreign" or invading organisms (e.g., antibodies) begin to attack healthy tissue for unknown reasons. Some cases may be linked to abnormal reactions by blood cells (serum antibodies), to a thyroid protein (thyroglobulin), organ wall (parietal) cells, adrenal cells, or thyroid. Symptoms of relapsing polychondritis may arise when autoantibodies attack human cartilage.
Some researchers believe that relapsing relapsing polychondritis may be caused by an immunologic sensitivity to type II collagen, a normal substance found in skin and connective tissue.
Relapsing polychondritis affects males and females in equal numbers. Symptoms usually begin between forty and sixty years of age.
Symptoms of the following disorders can be similar to those of relapsing polychondritis. Comparisons may be useful for a differential diagnosis:
Rheumatoid arthritis is a disease of unknown origin which may have a relationship to autoimmune processes. This disorder is characterized by lack of appetite (anorexia), tiredness, painful and deformed joints, early morning stiffness chiefly in the hands, knees, feet, jaw, and spine. Once affected, a patient's joints remain painful or uncomfortable for weeks, months, or even years.
Osteoarthritis is a degenerative joint disease of unknown origin characterized by loss of cartilage, deformities of bones with joints, and extra cartilage and bone growth at the joint margins with subsequent bony enlargement. Osteoarthritis develops when cartilage repair does not keep pace with degeneration. It may occur as a result of trauma to the bony or underlying joint disease.
Behcet syndrome is an inflammatory disorder affecting a number of organs. The most constant symptom is of oral and genital ulcers. Eye and joint inflammation, similar to Polychondritis, occurs. Blood vessels, the central nervous system, and the gastrointestinal tract may also be involved. Attacks last a week to a month, and can recur spontaneously. Some symptoms can appear as late as several years after onset of the disease which usually occurs between age 20 and 30. Twice as many men as women are affected. The disease is most common in the Middle East and Japan. For more information on the above disorder, choose "Behcet" as your search term in the Rare Disease Database.
Treatment of relapsing polychondritis usually involves the administration of corticosteroid drugs (e.g., prednisone), aspirin and non-steroidal anti-inflammatory compounds such as dapsone and/or colchicine. In extreme cases, drugs that suppress the immune system such as cyclophosphamide, 6-mercaptopurine and azathioprine may be recommended. In the most severe cases replacement of heart valves or the insertion of a breathing tube (tracheotomy) for collapsed airways may be necessary.
Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government website.
For information about clinical trials being conducted at the National Institutes of Health (NIH) in Bethesda, MD, contact the NIH Patient Recruitment Office:
Tollfree: (800) 411-1222
TTY: (866) 411-1010
For information about clinical trials sponsored by private sources, contact:
Some cases of relapsing polychondritis may go into remission after use of the immune suppressing drug cyclosporine-A. However, more research is necessary to determine complete safety and effectiveness of this treatment.
In the medical literature, there is a report of a child with relapsing polychondritis whose symptoms improved after treatment with type II collagen (CII). More research is necessary to determine the effectiveness and long-term safety of this potential treatment for relapsing polychondritis.
Stein, JH, ed. Internal Medicine. 4th ed. St. Louis, MO:Mosby-Year Book, Inc.; 1994:2406, 2465.
Kelley WN, et al., eds. Textbook of Rheumatology. 4th ed. Philadelphia, PA: W.B. Saunders Company; 1993:1400-09.
Navarro MJ, et al. Amelioration of relapsing polychondritis in a child treated with oral collagen. Am J Med Sci. 2002;324:101-3.
Letko E, et al. Relapsing polychondritis: a clinical review. Semin Arthritis Rheum. 2002;31:384-95.
Balsa-Criado A, et al. Cardiac involvement in relapsing polychondritis. Int J Cardiol. 1987;14:381-83.
Michet CJ, et al. Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med. 1986;104:74-78.
Krell WS, et al. Pulmonary function in relapsing polychondritis. Am Rev Respir Dis. 1986;133:1120-23.
Compton N. Polychondritis. Emedicine. http://emedicine.medscape.com/article/331475-overview. Updated January 19, 2012. Accessed February 15, 2012.
Genetic and Rare Diseases Information Center (GARD). Relapsing polychondritis. http://www.rarediseases.info.nih.gov/GARD/Disease.aspx?PageID=4&diseaseID=7417. Accessed February 15, 2012.
1330 West Peachtree Street, Suite 100
Atlanta, GA 30309
NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases
One AMS Circle
Bethesda, MD 20892-3675
Rheumatology Outpatient Clinic at Beth Israel Hospital
Division of Rheumotology
Department of Medicine
West Campus, Lowry Medical Office Building, 4B
110 Francis Street
330 Brookline Avenue
Boston, MA 02215
Genetic and Rare Diseases (GARD) Information Center
PO Box 8126
Gaithersburg, MD 20898-8126
PO Box 241956
Los Angeles, CA 90024
Autoimmune Information Network, Inc.
PO Box 4121
Brick, NJ 08723
European Society for Immunodeficiencies
1-3 rue de Chantepoulet
Geneva, CH 1211
Relapsing Polychondritis Awareness and Support Foundation, Inc.
PO Box 369
Anoka, MN 55303
Email: firstname.lastname@example.org; email@example.com
For a Complete Report
This is an abstract of a report from the National Organization for Rare Disorders, Inc.® (NORD). Cigna members can access the complete report by logging into myCigna.com. For non-Cigna members, a copy of the complete report can be obtained for a small fee by visiting the NORD website. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational treatments (if available), and references from medical literature. For a full-text version of this topic, see http://www.rarediseases.org/search/rdblist.html.
The information provided in this report is not intended for diagnostic purposes. It is provided for informational purposes only. NORD recommends that affected individuals seek the advice or counsel of their own personal physicians.
It is possible that the title of this topic is not the name you selected. Please check the Synonyms listing to find the alternate name(s) and Disorder Subdivision(s) covered by this report
This disease entry is based upon medical information available through the date at the end of the topic. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease Database completely current and accurate. Please check with the agencies listed in the Resources section for the most current information about this disorder.
For additional information and assistance about rare disorders, please contact the National Organization for Rare Disorders at P.O. Box 1968, Danbury, CT 06813-1968; phone (203) 744-0100; web site www.rarediseases.org or email firstname.lastname@example.org
Last Updated: 3/12/2012
Copyright 1988, 1989, 1991, 1998, 2002, 2007, 2009, 2012 National Organization for Rare Disorders, Inc.
Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.